Oncopeptides — Major Shareholding Notification 2021

Nov 5, 2021

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument	Aktier SE0009414576
Before the transaction
Shares	3,798,719
Voting rights	3,798,719
Transaction
Reason for major shareholding notification Sell
Date	04/11/2021
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,586,828
Directly held voting rights	0
Indirectly held voting rights	1,586,828
Percentage
Directly held shares	2.10757 %
Directly held voting rights	0 %
Indirectly held voting rights	2.10757 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	2.10757 %	1,586,828
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	2.10757 %	1,586,828
Chain of controlling companies Voting rights % Voting rights Company

Voting rights		1,586,828
Group total holdings
230,292	0.30587	Nordnet Livsforsikring AS
1,356,536 1.8017		Nordnet Pensionsförsäkring AB

Percentage of voting rights 2.10757

Notes (other relevant informations according to law)

Nordnet AB (publ) genom Nordnet Pensionsförsäkring AB och Nordnet Livsforsikring AS har underskridit tröskelvärdet 5% av antalet utestående aktier och röster till följd av nettosälj

Published

05/11/2021 11:50

Contact

Name Max Rhodin Edlund

Phone +46730487570 Email max.edlund@nordnet.se

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25